XML 87 R42.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation (Details Textuals) (USD $)
3 Months Ended 6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
Share-Based Compensation (Textuals) [Abstract]        
Stock option granted     0  
Aggregate intrinsic value of stock options exercised $ 1,300,000   $ 2,100,000  
Actual tax benefit realized on options exercised 513,000   833,000  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period     12,052  
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period     3 years  
Employee Stock Option [Member]
       
Share-Based Compensation (Textuals) [Abstract]        
Weighted-average period of recognition of unrecognized compensation cost     2 years 256 days  
Total unrecognized compensation cost 4,500,000   4,500,000  
Compensation cost charged against income 490,000 269,000 1,100,000 744,000
Income tax benefit recognized during the period 192,000 105,000 428,000 291,000
Nonvested Stock Awards [Member]
       
Share-Based Compensation (Textuals) [Abstract]        
Weighted-average period of recognition of unrecognized compensation cost     2 years 176 days  
Total unrecognized compensation cost 13,900,000   13,900,000  
Compensation cost charged against income 2,400,000 3,300,000 5,000,000 7,000,000
Income tax benefit recognized during the period 940,000 1,300,000 1,900,000 2,700,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period     12,000  
Restricted Stock Units (RSUs) [Member]
       
Share-Based Compensation (Textuals) [Abstract]        
Weighted-average period of recognition of unrecognized compensation cost     3 years 58 days  
Total unrecognized compensation cost 3,300,000   3,300,000  
Compensation cost charged against income 760,000   1,400,000 0
Income tax benefit recognized during the period $ 297,000   $ 533,000  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 0